Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 29, 2015
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 30, 2013
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 01, 2013
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 08, 2013
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2012
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 19, 2012
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 05, 2012
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 09, 2012
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Triligent International | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Rho Inc | Triligent International
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 24, 2011
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Rho Inc | Triligent International
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Ground Zero Pharmaceuticals | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose-Escalation Safety and Pharmacokinetic Study of K305
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 25, 2011
Lead Product(s) : Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Ground Zero Pharmaceuticals | Rho Inc
Deal Size : Inapplicable
Deal Type : Inapplicable